Tuberculosis is curable, but access to the drugs can be difficult not only because of cost, but also lack of availability, and affects all countries - high, medium and low-level income. This is a recording of the webinar held on 01 March 2024 to present the issues relating to availability (www.ucl.ac.uk/tb/access-drugs....
Speakers:
Christophe Perrin, TB advocacy Pharmacist, Médecins Sans Frontières
David Branigan, TB Project Officer, Treatment Action Group
Panel Members:
Tiziana Masini, independent consultant
Tifenn Humbert, WHO Euro Office Technical Officer
Негізгі бет Ғылым және технология Access to drugs for TB: Mapping issues, finding solutions
Пікірлер